Scientific advice and protocol assistance adopted during the CHMP meeting 13-16 October 2025
PSUSA/00002735/202501
Human medicines European public assessment report (EPAR): Omlyclo, omalizumab, Date of authorisation: 16/05/2024, Revision: 4, Status: Authorised
Scientific advice and protocol assistance adopted during the CHMP meeting 15-18 September 2025
Human medicines European public assessment report (EPAR): Voxzogo, vosoritide, Date of authorisation: 26/08/2021, Revision: 7, Status: Authorised
Human medicines European public assessment report (EPAR): Absimky, ustekinumab, Date of authorisation: 12/12/2024, Revision: 3, Status: Authorised
Fifth Veterinary Big Data Stakeholder Forum, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 10 November 2025, 09:00 (CET) to 10 November 2025, 17:30 (CET)
EMA's work on public health emergencies
EMA health threats plan - Annex 1: Acceleration of regulatory procedures during public health emergencies
EMA health threats plan